| Drug NDC: | 64578-0156 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Agri-chord |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Arsenicum Alb, Belladonna, Calc Carb, Ceanothus, Chelidonium Maj, Cuprum Sulph, Fumaricum Ac, Galium, Glandula Suprarenalis Suis, Hepar Suis, Kali Iod, Lycopodium, Pancreas Suis, Petroleum, Phosphoricum Ac, Phosphorus, Phytolacca, Sarsaparilla, Silicea, Sulphur, Thyroidinum, Trifolium Prat, Xanthoxylum, Zinc Phos |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Energetix Corporation |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | ARSENIC TRIOXIDE - 12 [hp_X]/59.1mL ATROPA BELLADONNA - 12 [hp_X]/59.1mL CEANOTHUS AMERICANUS LEAF - 6 [hp_X]/59.1mL CHELIDONIUM MAJUS - 12 [hp_X]/59.1mL CUPRIC SULFATE - 30 [hp_X]/59.1mL FUMARIC ACID - 30 [hp_X]/59.1mL GALIUM APARINE - 6 [hp_X]/59.1mL KEROSENE - 30 [hp_X]/59.1mL LYCOPODIUM CLAVATUM SPORE - 12 [hp_X]/59.1mL OYSTER SHELL CALCIUM CARBONATE, CRUDE - 30 [hp_X]/59.1mL Load more... PHOSPHORIC ACID - 12 [hp_X]/59.1mL PHOSPHORUS - 30 [hp_X]/59.1mL PHYTOLACCA AMERICANA ROOT - 4 [hp_X]/59.1mL PORK LIVER - 9 [hp_X]/59.1mL POTASSIUM IODIDE - 30 [hp_X]/59.1mL SARSAPARILLA - 12 [hp_X]/59.1mL SILICON DIOXIDE - 30 [hp_X]/59.1mL SULFUR - 30 [hp_X]/59.1mL SUS SCROFA ADRENAL GLAND - 9 [hp_X]/59.1mL SUS SCROFA PANCREAS - 9 [hp_X]/59.1mL THYROID, UNSPECIFIED - 9 [hp_X]/59.1mL TRIFOLIUM PRATENSE FLOWER - 4 [hp_X]/59.1mL ZANTHOXYLUM AMERICANUM BARK - 4 [hp_X]/59.1mL ZINC PHOSPHIDE - 30 [hp_X]/59.1mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 05 Apr, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 09 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Energetix Corporation |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| UNII: | S7V92P67HO WQZ3G9PF0H 25B1Y14T8N 7E889U5RNN LRX7AJ16DT 88XHZ13131 Z4B6561488 1C89KKC04E C88X29Y479 2E32821G6I Load more... E4GA8884NN 27YLU75U4W 11E6VI8VEG 6EC706HI7F 1C4QK22F9J 2H1576D5WG ETJ7Z6XBU4 70FD1KFU70 398IYQ16YV 9Y3J3362RY 0B4FDL9I6P 4JS0838828 A4KL1HMZ7T 813396S1PC |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 64578-0156-1 | 59.1 mL in 1 BOTTLE, DROPPER (64578-0156-1) | 24 Apr, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.